COVID-19 vaccination-induced Sweet syndrome in a patient with squamous cell carcinoma treated with nivolumab.

Authors :: Takahashi T
Fujimura T
Terui H
Asano Y
Source :: European journal of dermatology : EJD [Eur J Dermatol] 2024 Feb 01; Vol. 34 (1), pp. 98-100.
Publication Year :: 2024

Subjects :: Humans
COVID-19
Head and Neck Neoplasms
Neoplasm Recurrence, Local
Nivolumab therapeutic use
Carcinoma, Squamous Cell drug therapy
COVID-19 Vaccines adverse effects
Sweet Syndrome chemically induced

Full Text Access

Tools